“[Reply to Letter to the Editor in Reference to " Clinical and Economic Evaluation of the Introduction of the Combinazion Trametinib + Dabrafenib in the Management of Advanced Melanoma in the Italian market”]”. Farmeconomia. Health economics and therapeutic pathways 18, no. 1 (September 21, 2017). Accessed October 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/1329.